Phenomix Sciences Announces First Precision Obesity Biobanking Registry and Outcomes Study ...Middle East

Mayo Clinic first to enroll in registry with study of 2,000 patients being treated for obesity ST. PAUL, Minn., May 25, 2022 /PRNewswire/ -- Phenomix Sciences (Phenomix), a precision obesity biotechnology company, announces today the launch of its biobanking registry and outcomes study....

Hence then, the article about phenomix sciences announces first precision obesity biobanking registry and outcomes study was published today ( Wednesday 25/05/2022 - 09:13 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Phenomix Sciences Announces First Precision Obesity Biobanking Registry and Outcomes Study )

Also on site :

• Montran étend sa présence mondiale grâce à l'ouverture d'un nouveau bureau à Dubaï pour le Moyen-Orient et l'Afrique du Nord
• Claroty Secures $150 Million in Series F Funding to Lead Charge on Securing the World's Mission Critical Infrastructure
• Montran amplía su presencia global con una nueva oficina en Dubái para Oriente Medio y el Norte de África